Stryker Corporation (SYK)
Cash ratio
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 4,011,000 | 3,256,000 | 2,375,000 | 2,320,000 | 3,652,000 | 3,850,000 | 1,874,000 | 2,330,000 | 2,971,000 | 1,860,000 | 1,401,000 | 1,671,000 | 1,844,000 | 1,420,000 | 1,044,000 | 1,458,000 | 2,944,000 | 2,563,000 | 2,241,000 | 2,238,000 |
| Short-term investments | US$ in thousands | 89,000 | 87,000 | 89,000 | 89,000 | 841,000 | 834,000 | 83,000 | 77,000 | 82,000 | 76,000 | 77,000 | 86,000 | 84,000 | 77,000 | 83,000 | 72,000 | 75,000 | 76,000 | 84,000 | 74,000 |
| Total current liabilities | US$ in thousands | 7,794,000 | 7,414,000 | 7,288,000 | 7,929,000 | 7,616,000 | 7,669,000 | 6,926,000 | 6,955,000 | 7,921,000 | 7,458,000 | 6,584,000 | 5,866,000 | 6,303,000 | 4,571,000 | 4,404,000 | 4,408,000 | 4,549,000 | 4,449,000 | 4,252,000 | 3,953,000 |
| Cash ratio | 0.53 | 0.45 | 0.34 | 0.30 | 0.59 | 0.61 | 0.28 | 0.35 | 0.39 | 0.26 | 0.22 | 0.30 | 0.31 | 0.33 | 0.26 | 0.35 | 0.66 | 0.59 | 0.55 | 0.58 |
December 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($4,011,000K
+ $89,000K)
÷ $7,794,000K
= 0.53
Peer comparison
Dec 31, 2025
Company name
Symbol
Cash ratio
Stryker Corporation
SYK
0.53
Abbott Laboratories
ABT
0.53
CONMED Corporation
CNMD
0.12